- €499.32m
- €491.57m
- €788.37m
Halozyme makes 2 billion euro buyout offer for drug developer Evotec (updated)
Halozyme weighing buyout of drugmaker Evotec, Bloomberg News reports
Brief: Germany's Evotec Gets Takeover Interest From Halozyme At About 11 Euros Per Share - Bloomberg News
Evotec soars on Triton's near 10% stake, report it weighs buyout bid (updated)
Evotec shares jump as Triton becomes biggest shareholder with near 10% stake
Evotec falls on 9-month miss, 'no signs of recovery'
Corrected: BRIEF-Evotec 9M Adj. EBITDA Loss at EUR -6 Million
Brief: Evotec Confirms Guidance For 2024
Brief: Evotec Sells API Manufacturing Facility To Monacum Partners
Brief: Evotec Gets $50 Million Payment From Bristol Myers Squibb
Evotec slips after Jefferies cuts on uncertain strategy, market recovery timing
Europe Research Roundup: Borregaard ASA, Evotec SE, PVA TePla AG
Evotec and Novo Nordisk in technology development partnership (updated)
Evotec and Novo Nordisk forge technology development partnership
Brief: Evotec And Novo Nordisk Enter Into Technology Development Partnership To Support Next-Generation Cell Therapies
RCS - Infex Therapeutics - First NCFB patient dosed in RESP-X Phase IIa study
Brief: Evotec And X-Chem Collaborate To Accelerate Early-Stage Drug Discovery
Europe Research Roundup: Argenx, Glencore, Volvo Car
Evotec SE reports results for the quarter ended in June - Earnings Summary